Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Dopamine transmission mediated by D1 receptors essential for controlling movements in Parkinson's disease
Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson'...
FDA Approves Alkermes’ Schizophrenia Treatment Aristada
The Food and Drug Administration on Monday approved Alkermes PLC’s schizophrenia treatment clearing the way for the Dublin-based bio pharmaceutical company to start selling the drug.
Baxalta and Momenta Announce Initiation of Pivotal Clinical Trial for M923, a Biosimilar Version of HUMIRA (adalimumab)
BANNOCKBURN, IL and CAMBRIDGE, MA, USA I October 05, 2015.
New use of existing drug could help retrieve memory
Dementia and Alzheimer's can lead to total memory loss, affecting not only the capacity to process new ideas, but also motor function.
3 scientists share Nobel Prize for medicine for work on parasitic diseases
By Holly Yan and Jethro Mullen, CNN, October 5, 2015.
Teva buys Mexican pharmaceutical co Rimsa for $2.3b
Teva Pharmaceutical Industries Ltd.
Dompé and Omega Pharma sign OTC product range marketing deal
Dompé farmaceutici and Omega Pharma, a division of Perrigo Company, have signed an agreement for the international marketing of the OTC product range of the Italian biopharmaceutical Group.
Height May Be Linked to Increased Cancer Risk, Study Contends
THURSDAY, Oct.
Experimental drug shows promise in mice with multiple sclerosis
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a for...
New drug works better than current treatments for advanced kidney cancer
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, accordi...
FDA Accepts Sanofi's NDA for Lixisenatide
Sanofi announced that the U.
New Test Can Spot Almost Any Virus Infecting You…Or Your Dog
Scientists at the University School of Medicine in St.
648
649
650
651
652
653
654
655
656
